Archive Newsletter

21. 05.28.25 -- EMA Issues Draft Guideline On Quality Aspects Of mRNA Vaccines 5/28/2025
    05/28/25 Advancing RNA Newsletter
22. 05.27.25 -- Product Showcase: Advancing Your Molecule With Speed And Agility 5/27/2025
    05/27/25 Advancing RNA Newsletter
23. 05.21.25 -- Do We Really Understand Plasmid Quality's Effects On mRNA Production? 5/21/2025
    05/21/25 Advancing RNA Newsletter
24. 05.20.25 -- Do Your IVT mRNA Products Meet The Necessary Quality Guidelines? 5/20/2025

    05/20/25 Advancing RNA Newsletter

25. 05.14.25 -- Alnylam On Commercializing RNAi Therapies 5/14/2025
    05/14/25 Advancing RNA Newsletter
26. 05.07.25 -- How To Reduce mRNA Production COGS 5/7/2025
    05/07/25 Advancing RNA Newsletter
27. 04.30.25 -- Plasmid Production: 3 Takeaways For mRNA Manufacturing 4/30/2025
    04/30/25 Advancing RNA Newsletter
28. 04.23.25 -- Establishing Analytical Methods For mRNA-Based Therapies 4/23/2025
    04/23/25 Advancing RNA Newsletter
29. 04.21.25 -- Bringing Your mRNA-Based Drug From Pre-Clinical To Commercial 4/21/2025
    04/21/25 Advancing RNA Newsletter
30. 04.16.25 -- Britney Spears/ Take On mRNA Platform Analytics 4/16/2025
    04/16/25 Advancing RNA Newsletter